Severe obesity is associated with worse outcomes than lean metabolic dysfunction-associated steatotic liver disease.

Jaideep BehariRenwei WangHung N LuuDavid McKenzieMichele MolinariJian-Min Yuan

Published in: Hepatology communications (2024)

Patients with MASLD and very severe obesity (BMI ≥50 kg/m2) had the highest risk, exceeding that of patients with lean MASLD, for developing liver decompensation, obesity-associated extrahepatic cancers, or dying from any cause.

Keyphrases

insulin resistance
metabolic syndrome
weight gain
weight loss
high fat diet induced
type diabetes
body mass index
palliative care
oxidative stress
bone mineral density
young adults
postmenopausal women